Upstream and Downstream Processes of rFVIII Recombinant Protein Manufacturing in Respect to Fluid Flow, Mixing, Heat and Mass Transfer

Authors : Tevfik Gemci

Pages : 1358-1370

Doi:10.29130/dubited.1300873

View : 11 | Download : 31

Publication Date : 2024-07-31

Article Type : Review Paper

Abstract :The intrinsic blood coagulation pathways depend heavily on factor VIII, a glycoprotein cofactor. Hemophilia A, an X-linked dominant disease, is treated with FVIII, a very complex therapeutic protein commercially available. It is currently one of the most extensive and significant coagulation factors. Two isolated plasma and recombinant lyophilized FVIII concentrates are used to treat hemorrhagic illness in hemophilia A sufferers. Plasma-extracted products separated from humanoid blood can be substituted with recombinant FVIII (rFVIII) products, which are free of both humanoid and carnal proteins and transcribed in eukaryotic cells. In regard to fluid flow, mixing, heat, and mass transfer phenomena, the upstream and downstream manufacturing processes of rFVIII will be briefly reviewed in this publication.
Keywords : Rekombinant protein rFVIII üretimi, Yukarı akış ve aşağı akış süreçleri, Biyoreaktörlerde hücre çoğalması, Sıvı akışı, Isı ve kütle transferi